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Summary
Background: The implementation of automated tech-
niques improves the workflow and quality of immuno-
hematological results. The workflows of our university
blood bank were reviewed during the implementation of
an automated immunohematological testing system.
Methods: Work impact of blood grouping and subgroup-
ing, cross-matching and antibody search using the Im-
mucor Galileo system was compared to the previous
used standard manual and semi-automated methods.
Results: The redesign of our workflow did not achieve a
significant reduction of the specimen’s working process
time, the operator’s time however was reduced by 23%.
Corresponding results were achieved for blood group-
ing, Rhesus typing, antibody screen and for autocontrol
when changing from two semi-automated to the Galileo
system. Because of the higher sensitivity of the Immucor
antibody detection system, the rate of the initial positive
antibody screens rose from 4 to 6% Conclusion: The Im-
mucor Galileo system automates routine blood bank
testing with high reliability, specificity and higher sensi-
tivity compared to our previous used standard manual
and semi-automated methods.
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Zusammenfassung
Hintergrund: Die Einführung automatisierter Techniken
verbessert den Arbeitsablauf und die Qualität bei im-
munhämatologischen Untersuchungen. Die Arbeitspro-
zesse in unserer Blutbank wurden während der Einfüh-
rung eines neuen immunhämatologischen Testsystems
untersucht. Methoden: Die Arbeitsbelastung bei der Be-
stimmung von Blutgruppen und Blutuntergruppen, der
serologischen Verträglichkeitsprobe und der Antikörper-
suche mit dem Immucor-Galileo-System im Vergleich zu
den bisher benutzen manuellen und teilautomatisierten
Standardmethoden wurde untersucht. Ergebnisse: Die
Neuorganisation unserer Arbeitsprozesse führte zwar
nicht zur Verkürzung der eigentlichen Prozesszeit der
Probe, jedoch zu einer signifikanten Verkürzung der Zeit-
belastung der medizinisch-technischen Laborassistenten
in Höhe von 23%. Die Ergebnisse bei allen immunhäma-
tologischen Untersuchungen waren nach dem Wechsel
von den bisherigen zwei teilautomatisierten Methoden
zum Galileo-System vergleichbar. Die Rate der initial po-
sitiven Antikörpersuchen stieg aufgrund der höheren
Sensitivität des Immucor-Systems von 4 auf 6%. Schluss-
folgerung: Das Immucor-Galileo-System bietet bei der
Automation immunhämatologischer Routinetests (er-
weiterte Blutgruppenbestimmung, Antikörpersuche und
Kreuzprobe) eine hohe Reliabilität, Spezifität und eine
höhere Sensitivität verglichen mit unseren bisherigen
Standardmethoden.
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Introduction
The adoption of good manufacturing practice (GMP) and
good laboratory practice (GLP) requires an overall standard-
ization of laboratory testing methods used [1]. The implemen-
tation of automated techniques improves standardization of
methods and the quality of achieved results. Human errors in
manual processing are significant causes of fatal transfusion
complications [2–6]. We redesigned all immunohematological
routine testing processes at the blood bank of the Clinic of the
University of Munich in two branch sites according to GMP
and GLP by introduction of a new automated immunohema-
tological testing system.
The Clinic of the University of Munich is a large level IV uni-
versity based hospital. Our blood bank provides transfusions
for inpatients and outpatients from the hospital itself and from
area clinics and hospitals. The transfusion service (TS) per-
forms approximately 70,000 cross-matches for nearly 45,000
red blood cell units per year. Thereby nearly 35,000 blood
grouping and subgrouping orders for red cell antigens (ABH,
A1, A2, D, C, c, E, e, Cw and K1) and about 40,000 antibody
screens are done.
The Immucor Galileo  system (Immucor Medizinische Diag-
nostik GmbH, Rödermark, Germany) was developed to auto-
mate a high throughput repertory of immunohematology test-
ing using the Immucor Capture® solid phase technology. 
Our report embraces the implementation of automation and
data processing in both branch sites of the blood bank of the
Department of Transfusion Medicine and Hemostaseology of
the Clinic of the University of Munich using the Immucor
Galileo system and compares the workflow and the results of
routine blood bank testing by this system in an 1-year period
with those of the semi-automated methods used previously.
Assessment Goals and Scope
In view of the high and still growing order volume of routine
immunohematological tests in a relation of nearly 3 to 1 in
both branch sites of our blood bank, our institution was in in-
terested in exploring an automated solution for both high and
low throughput work more for a normal operation mode than
for working off emergency specimens, which remains the
sphere of immediate manual tube ABH and Rhesus (Rh) typ-
ing and cross-matching. Our evaluation centered on blood
grouping, subgrouping, antibody screen and cross-matching in
the areas of:
– pre-analytical and analytical workflow,
– material flow analysis (patients and blood donors speci-
mens),
– operator hands-on time, 
– daily work process,
– economy of space and costs.
Materials and Methods
Specimen and Request Form
Because of the service oriented alignment of our TS, samples and request
forms are incoming with two daily peaks at 11:00 am and 04:00 pm. Blood
grouping, Rh typing, antibody search and cross-matching for this report
were performed from the routine samples comparing the periods from
January 2005 to December 2005 for our previously used set of standard
manual and semi-automated methods, and February 2006 to January 2007
for the Immucor Galileo system. In January 2006 we monitored and re-
designed the workflows in our institution.
Monitoring and Redesign of our Workflow
To evaluate the workflow in our institution, the activities of the operators
were observed by an independent bystander. The workflow was docu-
mented by flow charts (Visio® 2003, Microsoft Deutschland GmbH, Un-
terschleißheim, Germany) and redesigned in order to fulfil the require-
ments for an optimal operating grade for the Galileo system and a high
utilization of automated methods. The abbreviated workflows are shown
in figure 1 and 2. Our previous workflow was characterized by a double
passing through in semi-automated system in order to achieve the com-
plete standard immunohematological results for each probe before cross-
matching. The redesigned workflow shows a single track solution
Previous Testing Systems
Blood grouping and subgrouping were done with the Immunoscan® plus
system (Ingen, Rungis, France). Main problems with this testing constella-
tion turned up with fulfilling the in vitro diagnostic directive of the EC
(98/79/EC). All testing sera with all new lots used have to be subjected to
a new inhouse validation after the dilution to the final working concentra-
tion for this device in our first branch institute. Our second branch insti-
tute worked standard tube tests.
Antibody search was done with an semi-automated testing system: Tecan
probe dispenser (Tecan Deutschland, Crailsheim, Germany) combined
with DiaMed test boxes (DiaMed Deutschland, Ottobrunn, Germany)
and semi-automated reading in a centrifuge. Here the problem was that
this particular testing configuration was not supported and maintained by
DiaMed anymore.
Immucor Galileo System
The Immucor Galileo system is a robotic instrument programmed to
move all of the necessary microplates, liquid reagents and blood samples
to the intended areas of processing for the given immunohematological
assays in the correct sequence (e.g. incubator bays, microplate washing
station, centrifuge, CCD camera reader). The software calculates a reac-
tion value for each well from the captured images. Result interpretation is
then assigned to the wells based on pre-defined criteria associated with
the calculation reaction value. The determination of results is based on
microplates and Immucor Capture solid phase technology. The device has
multitasking flexibilities with the ability to access samples and reagents
without interruption, perform multiple tests on each sample, and view re-
sults while running. A high throughput is ensured by two pipetting arms
that operate independently and simultaneously. The software and hard-
ware are optimized to an intuitive handling. The system may be used as an
independent system as well as connected to the customer laboratory in-
formation system (LIS) in terms of a bidirectional link with sample data
passing from the LIS to the Galileo and test results passing from the
Galileo to the LIS vice versa.
Transfus Med Hemother 2007;34:347–352Automation and Data Processing with the 




In the validation phase of implementation, the analyzer pro-
duced consistent results in routine samples in comparison with
our previous used manual and semi-automated methods. 1,500
specimens of patients and blood donors of our institution were
analyzed. Parallel blood grouping and subgrouping for red cell




tation of the Immucor
Galileo system.
350 Transfus Med Hemother 2007;34:347–352 Wittmann/Frank/Schramm/Spannagl
veal any discrepancies. Discrepancies were observed in anti-
body screening comparing the last 30,000 consecutive anti-
body screenings done with the previously used methods and
the first 30,000 screenings of the Galileo system. The Galileo
system revealed significantly more probes with initially
positive antibody search than our previous methods: 6
(1,789/30,000) versus 4% (1,193/30,000), p < 0.01 chi-square
test (Sigma-Stat 3.5, Systat software GmbH, Erkrath, Ger-
many). In the Galileo cohort two clinically highly significant
antibodies against public antigens Anti-Vel and Anti-AnWj
reacted only in the Galileo system. The increase in the Galileo
system of low-reactive antibodies such as Anti-Jka (n = 7),
Anti-Jkb (n = 5), Anti-Fya (n = 3), and Anti-Fyb (n = 4) not
detected by a consecutive testing in our previously used meth-
ods was remarkable. 
The workflow of the average day specimen load (70–95) was
manageable with an average labor utilization of 10.20 man
hours with the Galileo system. Thus, the demand dropped by
23% (13.25 versus 10.20 h). However, the turnaround time in
our TS was not shortened.
The error rate was equal; all investigated blood samples that
are performed in the two observation periods of 18 months,
were correctly identified.
With the new installation of the Galileo system we also re-
duced the space needed for the routine immunohematological
testing (2.3 m2).
The overall laboratory costs for the routine immunohemato-
logical testing in 2006 dropped by 3.7% in comparison to the




tion of the Immucor
Galileo system.
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In this study we report our experiences with the implementa-
tion of a new integrated automated system, Immucor Galileo.
We reviewed and redesigned our work processes in order to
improve our labor utilization as well as the economy of space
and costs. 
The demand for automation is evident across all laboratory
fields in transfusion medicine. Most of approaches have been
made in the great blood donation services to optimize stan-
dard blood grouping, serological testing for blood borne in-
fectious diseases and molecular tests, e.g. for HCV and HIV
RNA [7–11]. These automated methods have led to a remark-
able improvement in blood safety and to a considerable de-
crease of the risk of viral transmission [12]. The application of
automation is now growing in hospitals and transfusion ser-
vices, because human errors can lead to life threatening conse-
quences for the patients [7, 8, 13, 14]. 
In our report we compared the automatic Immucor Galileo
system with the established DiaMed typing system (gel cen-
trifugation test) using standard manual testing and our in-
house solution with a semi-automated system configuration
in terms of the detection of human blood typing, antibody
screening and cross-match testing. It is generally accepted
that gel technology is a highly sensitive method [15, 16]. Our
results indicate that the Immucor Galileo system performs
routine blood bank tests with the same accuracy like stan-
dard manual and semi-automated methods. The discrepan-
cies in the antibody screening are based on the higher sensi-
tivity of the Immucor Capture solid phase technology. This
benefit is accompanied on other hand by a higher expendi-
ture of time and effort for antibody identification or the ver-
ification of false-positive reactions in the initial antibody
search [17–19].
The advantage of all systems like the Immucor Galileo is the
system and process stability and the concordance with the
given standard operating procedures according to the de-
mands of GLP and the data security with automated reading,
positive sample and reagent identification, positive cassette
identification, reaction grading and interpretation of results. 
A still lasting disadvantage of all systems is emergency analy-
sis. Although interposition of emergency probes is possible
with several automated systems, automated blood typing sys-
tems are not capable to match the speed of an experienced
blood bank technologist performing a manual tube testing, ab-
breviated antibody screening and cross-match analysis. The
field will remain the sphere of manual methods, until new
technologies such as the lateral flow technique for rapid multi-
parameter blood grouping [20] are widely introduced. There-
fore, 10–15% of our samples are still tested manually.
Because we did no comparative studies with the competitors
in highly automated immunohematological testing system in
the market, e.g. the Ortho AutoVue® Innova System (Ortho-
Clinical Diagnostics GmbH, Neckargemünd, Germany) or the
Biotest Tango® optimo (Transfusion Biotest AG, Dreieich,
Germany), our results reflect only the improvements when
changing  from manual and semi-automated methods to a
fully automated system. Further investigations are necessary
to compare fully automated test systems in terms of quality,
speed and costs in routine immunohematology testing.
The Immucor Galileo system has now been effectively imple-
mented in our transfusion medicine institute for more than 18
months and still achieves the expectations in the everyday
routine work.
Conclusion
The Immucor Galileo system automates routine blood bank
testing including blood grouping and subgrouping (ABH, A1,
A2, D, C, c, E, e, Cw and K1), antibody search and cross-
matching with high reliability, specificity, and a higher sensitiv-
ity compared to our previously used methods. The system im-
proves GLP and quality in our institution in terms of consis-
tency and integrity of techniques and results by high standard-
ized procedures in pipetting, incubation, centrifugation,
reading and interpretation of results by automatic readers.
The total automation process reduces the employment of staff
facing a constant testing capacity of our laboratory. Compara-
tive studies among different fully automated systems and fur-
ther developments in the automation of emergency immuno-
hematology testing will have to be done.
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